Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.58 |
| ▸ | RECQL | P46063 | 8/20 | 0.58 |
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.58 |
| ▸ | USP2 | O75604 | 6/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | HBB | P68871 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.56 |
| ▸ | MMP2 | P08253 | 3/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 10/20 | 0.54 |
| ▸ | BLM | P54132 | 9/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | CASP1 | P29466 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | S100A4 | P26447 | 6/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 5/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rodorubicin SCHEMBL8693 | 1.00 | MEN1 (0.58) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL30504362 | 0.97 | PTGS1 (0.56) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL29403905 | 0.95 | PTGS1 (0.54) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL29356967 | 0.92 | PTGS1 (0.57) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL29557045 | 0.92 | MMP2 (0.58) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL29884381 | 0.92 | PTGS1 (0.67) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL29381144 | 0.88 | PTGS1 (0.50) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL2136732 | 0.87 | MEN1 (0.72) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL22589699 | 0.87 | MEN1 (0.72) | MEN1KMT2ARECQLMAPTSMN1; SMN2 | |
| SCHEMBL30714406 | 0.87 | MEN1 (0.72) | MEN1KMT2ARECQLMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| CN-119367549-A | Hydrophilic linkers and conjugates thereof | 芬兰吉利科斯有限公司 | 2025-01-28 | — | — | CN | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |
| EP-3541414-B1 | CONJUGATED BIOLOGICAL MOLECULES, PHARMACEUTICAL COMPOSITIONS AND METHODS | OBI PHARMA INC (TW) | 2024-08-28 | — | — | EP | claimed |
| CN-118251241-A | Antibodies, linkers, supports, conjugates and uses thereof | 启德医药科技（苏州）有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-3380124-B1 | CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO | LEGOCHEM BIOSCIENCES INC (KR) | 2024-04-03 | — | — | EP | claimed |
| EP-3122757-B1 | CHARGED LINKERS AND THEIR USES FOR CONJUGATION | HANGZHOU DAC BIOTECH CO LTD (CN) | 2023-09-06 | — | — | EP | claimed |
| EP-3641824-B1 | HYDROPHILIC LINKERS AND CONJUGATES THEREOF | GLYKOS FINLAND OY (FI) | 2022-08-31 | — | — | EP | claimed |
| EP-3218007-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | INST NAT SANTE RECH MED (FR) | 2022-04-06 | — | — | EP | claimed |
| WO-2026107389-A1 | CHROMATIN LANDSCAPES AND CELL-FREE DNA FRAGMENTATION FOR COLORECTAL CANCER DETECTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-117024411-B | Isoquinoline as HPK1 inhibitor | 豪夫迈·罗氏有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122028918-A | TRIM7 inhibitors and uses thereof | 沙塔克实验室有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122005761-A | Methods of treating diseases and conditions using interleukin-10 | 阿尔莫生物科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-120202022-A | Cell targeting constructs and uses thereof | 研究发展基金会 | 2025-06-24 | — | — | CN | disclosed |
| CN-114031689-A | Bispecific anti-human CD 20/human transferrin receptor antibodies and methods of use | 豪夫迈·罗氏有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-114014936-A | Bispecific anti-human CD 20/human transferrin receptor antibodies and methods of use | 豪夫迈·罗氏有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-114026106-A | Abiraterone prodrugs | 普洛拉治疗公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-113967194-A | Subcutaneous anti-HER 2 antibody formulation | 霍夫曼-拉罗奇有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113966344-A | anti-BCMA antibody conjugates, compositions comprising the same, and methods of making and using the same | 细胞基因公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113956358-A | anti-TIGIT antibodies and methods of use | 豪夫迈·罗氏有限公司 | 2022-01-21 | — | — | CN | disclosed |